Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Melnick

Showing results (281-290 of 322) with videos related to

Pageof 33
Sort By:
Blood Cancer Journal|July 5, 2023
Correction: Integrative analysis identifies an older female-linked AML patient group with better risk in ECOG-ACRIN Cancer Research Group's clinical trial E3999Franck Rapaport, Kenneth Seier, Yaseswini Neelamraju, et al.
Biorxiv : the Preprint Server for Biology|August 7, 2023
ChromaFold predicts the 3D contact map from single-cell chromatin accessibilityVianne R Gao, Rui Yang, Arnav Das, et al.
Nature Communications|January 15, 2025
Author Correction: ChromaFold predicts the 3D contact map from single-cell chromatin accessibilityVianne R Gao, Rui Yang, Arnav Das, et al.
Cancer Discovery|February 2, 2019
Molecular and Genetic Characterization of MHC Deficiency Identifies EZH2 as Therapeutic Target for Enhancing Immune RecognitionDaisuke Ennishi, Katsuyoshi Takata, Wendy Béguelin, et al.
Leukemia|December 30, 2015
Dnmt3a regulates myeloproliferation and liver-specific expansion of hematopoietic stem and progenitor cellsO A Guryanova, Y K Lieu, F E Garrett-Bakelman, et al.
Nature Communications|November 2, 2024
ChromaFold predicts the 3D contact map from single-cell chromatin accessibilityVianne R Gao, Rui Yang, Arnav Das, et al.
Cell|July 4, 2020
TBL1XR1 Mutations Drive Extranodal Lymphoma by Inducing a Pro-tumorigenic Memory FateLeandro Venturutti, Matt Teater, Andrew Zhai, et al.
Nature|December 10, 2020
H1 histones control the epigenetic landscape by local chromatin compactionMichael A Willcockson, Sean E Healton, Cary N Weiss, et al.
Cancer Discovery|May 12, 2019
Rational Targeting of Cooperating Layers of the Epigenome Yields Enhanced Therapeutic Efficacy against AMLCihangir Duy, Matt Teater, Francine E Garrett-Bakelman, et al.
Nature Medicine|September 15, 2015
The histone lysine methyltransferase KMT2D sustains a gene expression program that represses B cell lymphoma developmentAna Ortega-Molina, Isaac W Boss, Andres Canela, et al.
Pageof 33

Showing results (281-290 of 322) with videos related to

Sort By:
Pageof 33
Blood Cancer Journal|July 5, 2023
Correction: Integrative analysis identifies an older female-linked AML patient group with better risk in ECOG-ACRIN Cancer Research Group's clinical trial E3999Franck Rapaport, Kenneth Seier, Yaseswini Neelamraju, et al.
Biorxiv : the Preprint Server for Biology|August 7, 2023
ChromaFold predicts the 3D contact map from single-cell chromatin accessibilityVianne R Gao, Rui Yang, Arnav Das, et al.
Nature Communications|January 15, 2025
Author Correction: ChromaFold predicts the 3D contact map from single-cell chromatin accessibilityVianne R Gao, Rui Yang, Arnav Das, et al.
Cancer Discovery|February 2, 2019
Molecular and Genetic Characterization of MHC Deficiency Identifies EZH2 as Therapeutic Target for Enhancing Immune RecognitionDaisuke Ennishi, Katsuyoshi Takata, Wendy Béguelin, et al.
Leukemia|December 30, 2015
Dnmt3a regulates myeloproliferation and liver-specific expansion of hematopoietic stem and progenitor cellsO A Guryanova, Y K Lieu, F E Garrett-Bakelman, et al.
Nature Communications|November 2, 2024
ChromaFold predicts the 3D contact map from single-cell chromatin accessibilityVianne R Gao, Rui Yang, Arnav Das, et al.
Cell|July 4, 2020
TBL1XR1 Mutations Drive Extranodal Lymphoma by Inducing a Pro-tumorigenic Memory FateLeandro Venturutti, Matt Teater, Andrew Zhai, et al.
Nature|December 10, 2020
H1 histones control the epigenetic landscape by local chromatin compactionMichael A Willcockson, Sean E Healton, Cary N Weiss, et al.
Cancer Discovery|May 12, 2019
Rational Targeting of Cooperating Layers of the Epigenome Yields Enhanced Therapeutic Efficacy against AMLCihangir Duy, Matt Teater, Francine E Garrett-Bakelman, et al.
Nature Medicine|September 15, 2015
The histone lysine methyltransferase KMT2D sustains a gene expression program that represses B cell lymphoma developmentAna Ortega-Molina, Isaac W Boss, Andres Canela, et al.
Pageof 33